Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 23 Jun 2026

Wang F X, Ning T, Bai M, Duan J J, Mo Y Q, Deng T

Abstract excerpt

Objective: To analyze the clinicopathological characteristics, treatment, and prognosis of SMARCA4-deficient tumors of digestive system origin, and to deepen the understanding of this tumor subtype. Methods: A retrospective analysis was conducted on 18 patients diagnosed with SMARCA4-deficient tumors of digestive system origin at Tianjin Medical University Cancer Institute and Hospital from January 1, 2021 to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Bile Duct Neoplasms
Share to Digestive System Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Helicases

Share to Gallbladder Neoplasms

Share to Liver Neoplasms

Share to Stomach Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 42331552
DOI: 10.3760/cma.j.cn112152-20251229-00643

Genes

SMARCA4
IMPACT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Clinicopathological analysis of SMARCA4-deficient tumors of digestive system origin].PMID 42331552Read ↗

[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].Semantic proximity Read ↗

Primary SMARCB1-deficient intestinal carcinoma: Clinicopathological and molecular characterization of three cases with analysis of published data.Semantic proximity Read ↗

[Clinical characteristics and prognostic analysis of thoracic SMARCA4-deficient undifferentiated tumor].Semantic proximity Read ↗

Gastric SMARCA4-deficient undifferentiated tumor (SMARCA4-UT): a clinicopathological analysis of four rare casesSemantic proximity Read ↗

SMARCA4 Mutations in Carcinomas of the Esophagus, Esophagogastric Junction, and Stomach.Semantic proximity Read ↗

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods.Semantic proximity Read ↗

Clinical characteristics and association with immunotherapy outcomes in SMARCA4-deficient NSCLCSemantic proximity Read ↗

[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].Semantic proximity Read ↗

Clinicopathological characteristics and treatment outcomes of advanced SMARCA4-deficient thoracic tumors.Semantic proximity Read ↗

Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.Semantic proximity Read ↗

Esophageal carcinoma with SMARCA4 mutation: Unique diagnostic challenges.Semantic proximity Read ↗

Comprehensive Analysis of SMARCB1 and SMARCA4 Expression Profiles and Their Clinical Correlations in Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.